These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14609956)

  • 1. hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci.
    Sharma M; Li X; Wang Y; Zarnegar M; Huang CY; Palvimo JJ; Lim B; Sun Z
    EMBO J; 2003 Nov; 22(22):6101-14. PubMed ID: 14609956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes.
    Huang CY; Beliakoff J; Li X; Lee J; Li X; Sharma M; Lim B; Sun Z
    Mol Endocrinol; 2005 Dec; 19(12):2915-29. PubMed ID: 16051670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.
    Lee J; Beliakoff J; Sun Z
    Nucleic Acids Res; 2007; 35(13):4523-34. PubMed ID: 17584785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.
    Beitel LK; Elhaji YA; Lumbroso R; Wing SS; Panet-Raymond V; Gottlieb B; Pinsky L; Trifiro MA
    J Mol Endocrinol; 2002 Aug; 29(1):41-60. PubMed ID: 12200228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
    J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.
    Peng Y; Lee J; Zhu C; Sun Z
    J Biol Chem; 2010 Apr; 285(15):11465-75. PubMed ID: 20159969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
    Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer.
    Bahnassy S; Thangavel H; Quttina M; Khan AF; Dhanyalayam D; Ritho J; Karami S; Ren J; Bawa-Khalfe T
    Cell Commun Signal; 2020 Sep; 18(1):154. PubMed ID: 32948192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis.
    Tan J; Hall SH; Hamil KG; Grossman G; Petrusz P; Liao J; Shuai K; French FS
    Mol Endocrinol; 2000 Jan; 14(1):14-26. PubMed ID: 10628744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
    Li N; Chen M; Truong S; Yan C; Buttyan R
    Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
    Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
    Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
    Gross M; Yang R; Top I; Gasper C; Shuai K
    Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
    Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
    Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of a polyglutamine tract in the function of the human androgen receptor.
    Callewaert L; Christiaens V; Haelens A; Verrijdt G; Verhoeven G; Claessens F
    Biochem Biophys Res Commun; 2003 Jun; 306(1):46-52. PubMed ID: 12788064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
    Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
    Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
    Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
    Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.